U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06838195) titled 'Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate Vaccine' on Feb. 07.
Brief Summary: The goal of this clinical trial is to evaluate the protective efficacy of S. Flexneri-S. Sonnei bivalent conjugate vaccine against diarrhea caused by Shigella infection in infants and children aged 6 months to 5 years. Researchers will observe the incidence of diarrhea of any severity due to Shigella flexneri and Shigella sonnei infection 30 days after full immunization. The subjects will receive 2 doses of vaccination.
Study Start Date: April 15
Study Type: INTERVENTIONAL
Condition:
Dysentery
Dysentery, Shigella
Intervention:
BI...